Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with a diagnosis of endometriosis:
- Women and people assigned female at birth who have not yet reached menopause
- Aged 18 years or older
- Have been diagnosed with endometriosis through surgery or medical imaging within the last 5 years
- Able to understand and willing to sign a consent form
For healthy volunteers (no endometriosis):
- Women and people assigned female at birth
- Aged 18 years or older
- No history of endometriosis or ongoing pelvic pain
- Able to understand and willing to sign a consent form
Who may not be able to join:
For both groups:
- Those who have donated blood (450 ml) in the last 4 weeks
- Those with a known cancer of the reproductive tract
- Those with diagnosed eye conditions such as glaucoma, optic nerve disease, cataracts, macular degeneration, or retinal disorders
- Those with a very strong glasses or contact lens prescription (high short-sightedness, long-sightedness, or significant astigmatism — confirm exact thresholds with trial site)
- Those who have had eye surgery, such as laser vision correction or retinal surgery
- Those with significant eye injury, corneal problems, or an active eye infection
- Those with diabetes
Additionally, for healthy volunteers only:
- Those who have experienced symptoms that may suggest endometriosis or long-term pelvic pain
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrew Horne, University of Edinburgh
Phone: +447301394870
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Choroidal Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Nerve Fiber Layer (RNFL) Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Macular Volume (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Vessel Density (Optical Coherence Tomography Angiography, Heidelberg SPECTRALIS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.